Previous 10 | Next 10 |
Blueprint Medicines ( BPMC +10.7% ) is poised for its best one-day gain in a month on the heels of a note from SVB Leerink on RET inhibitor pralsetinib (BLU-667). More news on: Blueprint Medicines Corporation, Eli Lilly and Company, Healthcare stocks news, Stocks on the move, Read mo...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Image source: The Motley Fool. Blueprint Medicines (NASDAQ: BPMC) Q1 2020 Earnings Call May 06, 2020 , 8:30 a.m. ET Operator Continue reading
Blueprint Medicines Corporation (BPMC) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Kristin Hodous - Senior Manager, IR Jeff Albers - CEO Christy Rossi - Chief Commercial Officer Mike Landsittel - CFO Andy Boral - Chief Medical Officer Con...
Blueprint Medicines (NASDAQ: BPMC ): Q1 GAAP EPS of -$2.11 beats by $0.05 . More news on: Blueprint Medicines Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
CAMBRIDGE, Mass. , May 6, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today reported financial results and provided a business update for the first qua...
Aurinia Pharmaceuticals (AUP CN) initiated with Outperform rating and C$30 (29% upside) price target at Cowen and Company. No premarket activity yet (NASDAQ: AUPH ) in U.S. More news on: Aurinia Pharmaceuticals Inc., Blueprint Medicines Corporation, Cytokinetics, Incorporated, Healthcare s...
CAMBRIDGE, Mass. , April 29, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a live conference call and webcast at 8:30 a.m. ...
Gainers: Creative Realities (NASDAQ: CREX ) +125% . More news on: Creative Realities, Inc., Syndax Pharmaceuticals, Inc., Kura Oncology, Inc., Stocks on the move, , Read more ...
Shares of Blueprint Medicines (NASDAQ: BPMC) fell nearly 21% today after the company announced that its lead drug candidate, avapritinib, failed an important late-stage study in gastrointestinal stromal tumors (GIST). The experimental therapy didn't lead to an improvement in progression-free...
News, Short Squeeze, Breakout and More Instantly...
Blueprint Medicines Corporation Company Name:
BPMC Stock Symbol:
NASDAQ Market:
Blueprint Medicines Corporation Website:
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 PR Newswire CAMBRIDGE, Mass. , April 18, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and w...
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics PR Newswire -- Dr. Mariana Castells , M.D., Ph.D., a renowned researcher and clinical expert in mast cell diseases, will join members ...
2024-04-10 04:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...